The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia

British Journal of Haematology

Volumn 93, Issue 2, 1996, Pages 333-340

  Dias Da Motta, Péricles M ^a   Arruda, Valder R ^a   Muscará, Marcelo N ^a   Saad, Sara T O ^a   De Nucci, Gilberto ^a   Costa, Fernando F ^a   Condino Neto, Antonio ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

free radicals; human; leucocytes; microcirculation; sickle cell disease

Indexed keywords

ARGININE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHORBOL ESTER; SUPEROXIDE; ZYMOSAN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0029926694     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4951036.x     Document Type: Article

References (45)

1. Babior, B.M. (1984) Oxidants from phagocytes: agents of defense and destruction. Blood, 64, 959-966.
2. Babior, B.M., Curnutte, J.T. & McMurrich, B.J. (1973) The particulate superoxide-forming system from human neutrophils: Properties of the system and further evidence supporting its participation in the respiratory burst. Journal of Clinical Investigation, 58, 989-992.
3. Bookchin, R.M. & Lew, V.L. (1983) Red cell membrane abnormalities in sickle-cell anemia. Progress in Hematology, 13, 1-13.
4. Born, G.V.R. & Cross, M.J. (1963) The aggregation of blood platelets. Journal of Physiology, 168, 178-195.
5. Briehl, R.W. & Ewert, S. (1974) Gelatin of sickle cell hemoglobin. II. Methemoglobin. Journal of Molecular Biology, 89, 759-766.
6. Chien, S., Usami, S. & Bertles, J.F. (1970) Abnormal rheology of oxygenated blood in sickle cell anemia. Journal of Clinical Investigation, 49, 623-629.
7. Condino-Neto, A., Muscará, M.N., Grumach, A.S., Carneiro-Sampaio, M.M.S. & de Nucci, G. (1993) Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide. British Journal of Clinical Pharmacology, 35, 485-490.
8. Curnutte, J.T. (1993) Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clinical Immunology and Immunopathology, 67, (Suppl.), 2-15.
9. Curnutte, J.T., Whitten, D.M. & Babior, B.M. (1974) Defective superoxide production by granulocytes from patients with chronic granulomatous disease. New England Journal of Medicine, 290, 593-597.
10. Emerson, J.D. & Strenio, H. (1983) Box-plots and batch comparison. Understanding Robust and Exploratory Data Analysis (ed. by D. C. Hoaglin, F. Mosteller and J. M. Tukey), p. 58. John Wiley & Sons, New York.
11. English, D. & Andersen, B.R. (1974) Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradient of Ficoll-Hypaque. Journal of Immunological Methods, 5, 249-252.
12. Fridovich, I. (1978) The biology of oxygen radicals. Science, 201, 875-880.
13. Furchgott, R.F. & Zawadski, J.V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
14. Griffith, T.M., Edwards, D.H., Lewis, M.J., Newby, A.C. & Henderson, A.M. (1984) The nature of endothelium-derived vascular relaxant factor. Nature, 308, 645-647.
15. Gryglewski, R.J., Palmer, R.M.J. & Moncada, S. (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320, 454-456.
16. Hamberg, M., Svensson, J. & Samuelsson, B. (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Sciences of the United States of America, 72, 2994-3001.
17. Hamberg, M., Svensson, J., Wakabayashi, T. & Samuelsson, B. (1974) Isolation and structures of two prostaglandin endoperoxides that cause platelet aggregation. Proceedings of the National Academy of Sciences of the United States of America, 71, 345-352.
18. Holmes, B., Page, A.R. & Good, R.A. (1967) Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocyte function. Journal of Clinical Investigation, 46, 1422-1432.
19. Joseph, M., Capron, A., Tsicopoulos, A., Ameisen, J.C., Martinot, J.B. & Tonnel, A.B. (1987) Platelet activation by IgE and aspirin. Agents and Actions, 21, (Suppl. 1), 169-177.
20. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension, 15, 475-481.
21. Kay, A.B. & Corrigan, C.J. (1992) Eosinophils and neutrophils. British Medical Bulletin, 48, 51-64.
22. 4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins, 27, 163-179.
23. Martin, W., Villani, G.M., Jothianandan, D. & Furchgott, R.F. (1985) Selective blockade of endothelial-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. Journal of Pharmacology and Experimental Therapeutics, 232, 708-716.
24. McCord, J. & Fridovich, I. (1969) Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry, 244, 6044-6055.
25. Moncada, S., Gryglewski, R., Bunting, S. & Vane, J.R. (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature, 263, 663-665.
26. Moncada, S., Palmer, R.M.J. & Gryglewski, R.J. (1986) Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proceedings of the National Academy of Sciences of the United States of America, 83, 9164-9168.
27. G-Nitroarginine (L-NOARG) a novel L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. British Journal of Pharmacology, 99, 408-412.
28. Mosseri, M., Bartlett-Pandite, A.N., Wenc, K., Isner, J.M. & Weinstein, R. (1993) Inhibition of endothelium-dependent vasorelaxation by sickle erythocytes. American Heart Journal, 126, 338-346.
29. Palmer, R.M.J., Ashton, D.S. & Moncada, S. (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
30. Pembrey, M.E., MacWade, P. & Weatherall, D.J. (1972) Reliable routine estimation of small amounts of faetal haemoglobin by alkaly desnaturation. Journal of Clinical Pathology, 25, 738-740.
31. Radomski, M.W. & Moncada, S. (1983) An improved method for washing human platelets with prostacyclin. Thrombosis Research, 30, 383-399.
32. Radomski, M.W., Palmer, R.M.J. & Moncada, S. (1987a) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. British Journal of Pharmacology, 92, 181-187.
33. Radomski, M.W., Palmer, R.M.J. & Moncada, S. (1987b) The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. British Journal of Pharmacology, 92, 639-646.
34. Radomski, M.W., Palmer, R.M.J. & Moncada, S. (1987c) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochemical and Biophysical Research Communications, 148, 1482-1489.
35. Radomski, M.W., Palmer, R.M.J. & Moncada, S. (1987d) Endogenous nitric oxide inhibits human platelet adhesions to vascular endothelium. Lancet, ii, 1057-1058.
36. Rapoport, R.M. & Murad, F. (1983) Agonist induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circulation Research, 52, 352-357.
37. Rubanyi, G.M. & Vanhoute, P.M. (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. American Journal of Physiology, 250, 822-827.
38. Salvemini, D., de Nucci, G., Gryglewski, R.J. & Vane, J.R. (1989) Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing an EDRF-like factor. Proceedings of the National Academy of Sciences of the United States of America, 86, 6328-6332.
39. Segal, A.W. & Abo, A. (1993) The biochemica basis of the NADPH-oxidase of phagocytes. Trends in Biochemical Sciences, 18, 43-47.
40. Smith, C.M., Kuettner, J.F., Tukey, D.P., Burris, S.M. & White, J.G. (1981) Variable deformability of irreversibility sickled erythrocytes. Blood, 58, 71-76.
41. Warner, T.D., De Nucci, G. & Vane, J.R. (1989) Comparison of the survival of endothelium-derived relaxing factor and nitric oxide within the isolated perfused mesentary of the rat. British Journal of Pharmacology, 97, 777-782.
42. Weathrall, D.J. & Clegg, B. (1981) The Thalassaemia Syndromes, pp. 754-769. Blackwell Scientific Publications, Oxford.
43. Yanagisawa, K., Kurihara, H., Kimura, S., Tomobe. Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. & Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
44. Zago, M.A., Costa, F.F. & Bottura, C. (1982) Teste de solubilidade quantitativo modificado em hemolisados normais e em variantes de hemoglobina. Revista Paulista de Medicina, 100, 15-17.
45. Zar, J.H. (1988) Non-parametric statistical methods. Biostatistical Analysis, pp. 138-141. Prentice Hall, New York.